Randomized trial comparing partial versus complete chordal-sparing mitral valve replacement: Effects on left ventricular volume and function  by Yun, Kwok L. et al.
Randomized trial comparing partial versus complete
chordal-sparing mitral valve replacement: Effects on left
ventricular volume and function
Kwok L. Yun, MD
Colleen F. Sintek, MD
D. Craig Miller, MDa
Thomas A. Pfeffer, MD
Gary S. Kochamba, MD
Siavosh Khonsari, MD
Michael R. Zile, MDb
Yun, Khonsari, Sintek (left to right)
Objective: The merits of retaining the subvalvular apparatus during mitral valve
replacement for chronic mitral regurgitation have been demonstrated in numerous
retrospective clinical investigations but not in a randomized study. In this report we
analyzed the early and late effects of complete versus partial chordal preservation on
left ventricular mechanics.
Methods: Forty-seven patients undergoing isolated surgical correction of mitral insuf-
ficiency were prospectively randomized to either total or partial chordal-sparing mitral
valve replacement. Complete data from 36 patients were available for analysis. Of these
individuals, 15 had preservation of the posterior leaflet only (P-MVR group), and 21 had
complete preservation of all chordal structures (C-MVR group). Echocardiography was
performed preoperatively, at the time of discharge, and after 1 year to determine
dimensions, wall stress, left ventricular mass, and ejection function.
Results: End-diastolic volume decreased in both groups initially but continued to
decline only in the C-MVR cohort. Similarly, although end-systolic volume de-
creased over time with total chordal preservation, no notable changes were observed
in the P-MVR group. In the C-MVR group, end-systolic stress decreased initially
but rose slightly by 1 year. In contrast, end-systolic stress remained unchanged at
discharge in the P-MVR group and increased at 1 year. In terms of systolic performance,
ejection fraction declined after surgical intervention with partial chordal-sparing tech-
niques and did not improve by 1 year. Ejection fraction returned to the preoperative level
after an initial decrease in the C-MVR group. Finally, left ventricular mass was reduced
in the C-MVR cohort versus no change in the P-MVR group.
Conclusion: Complete retention of the mitral subvalvular apparatus during mitral
valve replacement confers a significant early advantage by reducing left ventricular
chamber size and systolic afterload compared with partial chordal preservation.
Furthermore, left ventricular ejection performance continues to improve over time,
probably because of more favorable left ventricular remodeling.
The early1-3 and late4-6 hemodynamic benefits of preserving the mitralsubvalvular apparatus during mitral valve replacement (MVR) havebeen demonstrated in several studies. Although some investiga-tors4,7,8 have retrospectively examined the issue of complete versuspartial chordal preservation, this question has not been addressedrigorously in the clinical setting with extended follow-up. As a
result, many surgeons continue to retain only the posterior leaflet chordae tendineae
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because of concerns over greater technical complexity,
longer operating time, potential interference with mechani-
cal valve leaflet motion, need to undersize the mitral pros-
thesis, and the possibility of creating left ventricular (LV)
outflow tract obstruction.9 In a recent preliminary analysis10
of the first 19 patients in this larger prospective, randomized
trial, we reported superior LV systolic performance of com-
plete (bileaflet) chordal sparing during MVR compared with
partial (posterior leaflet only) chordal preservation for iso-
lated mitral regurgitation early postoperatively. In this study
the complete data set, along with 1-year follow-up echocar-
diographic results, are presented.
Methods
Between March 1996 and April 1998, 47 patients undergoing
MVR for chronic mitral regurgitation at Southern California Kai-
ser Permanente Medical Center in Los Angeles were prospectively
randomized to either partial (posterior leaflet) or complete (ante-
rior and posterior) chordal preservation groups. Originally, the
study was designed for 50 patients. However, because of time and
resource constraints, a termination date was set at the end of a
2-year period. As a result, only 47 patients were enrolled in the
study. Of these patients, 22 underwent partial (P-MVR group) and
25 had complete (C-MVR group) preservation of the mitral sub-
valvular apparatus. All valves were deemed to be nonreparable at
the time of operation by the surgeon. Those patients with evidence
of coronary artery disease or substantial mitral stenosis (mean
transvalvular gradient 5 mm Hg) were excluded. Informed con-
sent was obtained from all patients, and the protocol was approved
by our institution’s investigational review board.
Surgical Techniques
Standard moderate hypothermic (approximately 28°C-32°C) car-
diopulmonary bypass was used. Myocardial protection consisted
of intermittent antegrade, retrograde, or both cold hyperkalemic
cardioplegia. In patients randomized to the partial chordal-sparing
technique, the anterior leaflet, along with its attached chordae
tendineae, was excised. The posterior leaflet and its chordal at-
tachments were preserved. If the posterior leaflet was excessively
redundant or the chordae tendineae were elongated, the leaflet was
imbricated into the mitral anulus with the valve sutures. In those
patients randomized to complete chordal preservation, the entire
subvalvular apparatus was preserved in an anatomic fashion, as
described by Sintek and associates.11 In brief, the anterior leaflet
was detached 3 mm from the anulus, and a central ellipse-shape
portion was excised, leaving a 5- to 10-mm rim of leaflet-free edge
attached to the primary (first order or marginal) chordae tendineae.
This strip of leaflet was then reattached to the anulus in the
corresponding location with the valve sutures (Khonsari II tech-
nique). Alternatively, if the anterior leaflet was excessively redun-
dant, it was divided into 2 to 4 segments, which were then
resuspended in a normal anatomic position with the valve sutures
(Khonsari I technique).
Echocardiographic Studies and Measurements
Two-dimensional, M-mode, and color-flow Doppler transthoracic
echocardiography with standard acoustic windows were performed
in all patients just before operation, at the time of hospital dis-
charge, and after 1 year. All study results were read by one
observer (M.R.Z.) in a blinded fashion on completion of the
investigation. Mean values for each measurement were derived
from 3 consecutive heart beats in patients in sinus rhythm and from
5 beats in those in atrial fibrillation. End-diastole was defined as
the onset of the electrocardiographic Q wave, and end-systole was
defined as the time of minimum LV dimension. Instantaneous LV
volume (V) was calculated as follows:
V  /6D2L,
where D is the LV minor-axis dimension acquired from the short-
axis view, and L is the long-axis dimension acquired from the
apical 4-chamber view. Ejection fraction (EF) was computed by
using LV end-diastolic volume (EDV) and end-systolic volume
(ESV). Similarly, long-axis fractional shortening (LAFS) was de-
termined by using end-diastolic and end-systolic long LV-axis
dimensions. Midwall circumferential end-systolic LV stress (ESS),
a clinically useful estimate of LV afterload, was calculated by
using Mirsky’s formula12 for a prolate ellipsoid as follows:
ESS  Pb/h[1 – (h/[2b]) – (b2/[2a2])  1.332 kdyne/cm2,
where P is 0.98 times the mean arterial (cuff) pressure plus 11 mm
Hg,7 h is the end-systolic wall thickness, b is the end-systolic
semiminor axis ([Dh]/2), and a is the end-systolic semimajor
axis ([Lh]/2). Mean arterial cuff pressure was defined as follows:
[Systolic blood pressure  2 (Diastolic blood pressure)]/3.
The ESS/ESV ratio was also computed as a relatively less load-
sensitive index of LV systolic performance.13 Finally, LV mass
(LVM) was estimated by the following formula14:
LVM  1.04  ([D2h]3 – D3) – 14.
Statistical Analysis
All data are expressed as means  SD unless specified otherwise.
Demographic characteristics of each surgical group were com-
pared with the Fisher exact test for categoric variables and the
unpaired t test for continuous variables. Repeated-measures anal-
ysis of variance was used to assess the influence of time (preop-
eratively vs postoperatively vs 1 year) and type of procedure
(P-MVR vs C-MVR) on all echocardiographic derived parameters.
If a significant F value resulted, the Scheffe test was performed to
determine which individual differences may be important. The
differences between the 2 groups in the changes of the discharge
and 1-year values from baseline were assessed by using the un-
paired t test.
Results
Two patients were lost to follow-up (one in each group).
Two patients in the P-MVR group died 9 days after the
operation as a result of deteriorating hemodynamics and
multiorgan system failure. Three 1-year follow-up echocar-
diographic studies in the P-MVR group, performed at their
respective satellite facilities, were of such poor quality that
accurate measurements were not possible. Furthermore, it
was predetermined at the initiation of the study that patients
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with preoperative end-systolic diameters of greater than 50
mm were to be excluded from analysis because a poor
outcome has previously been demonstrated in those under-
going MVR with such LV decompensation, despite chordal
preservation.15-19 Four patients (3 in the C-MVR and 1 in
the P-MVR group) fell into this category. Consequently,
data from 36 patients (21 in the C-MVR and 15 in the
P-MVR group) were included in the final analysis.
Selected preoperative patient characteristics according to
operative procedure group are summarized in Table 1. Most
patients had myxomatous degenerative changes of the mi-
tral leaflets and subvalvular apparatus. Although there was
a greater percentage of male patients in the C-MVR cohort,
no differences were noted in terms of age or preoperative
New York Heart Association classification. Intraopera-
tively, 26 St Jude (St Jude Medical, Inc) bileaflet mechan-
ical prostheses (13 in each group) and 10 Hancock
(Medtronic, Inc) porcine valves (8 in the C-MVR and 2 in
the P-MVR group) were inserted (P  .21).
The echocardiographically measured EDV, ESV, ESS,
EF, LAFS, and LVM values, as well as the calculated
ESS/ESV ratios, are shown in Table 2. Preoperatively,
patients in the C-MVR group had larger hearts, greater ESS,
and lower ejection performance. Two-way repeated-meas-
ures analysis of variance demonstrated that although EDV
decreased from the preoperative level at the time of dis-
charge in both groups, it fell further only in the C-MVR
cohort after 1 year. Similarly, although ESV continued to
decline over time in those with total chordal preservation,
no notable changes were observed in the P-MVR group. In
the C-MVR group ESS decreased initially but rose slightly
at 1 year. In contrast, ESS remained unchanged at the
discharge study in the P-MVR patients and increased by 1
year. In terms of ejection performance, both EF and LAFS
decreased after operation with partial chordal preservation
and did not improve by 1 year. On the other hand, EF and
LAFS in the C-MVR cohort returned to the preoperative
level after initial declines. As a relatively load-insensitive
index of systolic performance, the ESS/ESV ratio markedly
improved after 1 year in the C-MVR group. In the P-MVR
patients the 1-year value of ESS/ESV trended back toward
the preoperative level after a significant decline at dis-
charge. Finally, LVM was reduced in the C-MVR cohort
versus no change in those in the P-MVR group. The per-
centage changes at discharge and at 1 year from preopera-
tive levels are depicted in Figures 1 and 2, respectively.
Of the 4 patients with preoperative end-systolic diame-
ters greater than 50 mm (1 in the P-MVR and 3 in the
C-MVR group), only one had reductions in EDV, ESV,
ESS, and LVM and improvement in EF, LAFS, and ESS/
ESV ratio after 1 year. This individual had complete pres-
ervation of the subvalvular apparatus. The remaining 3
patients had worsening LV mechanics with time. The one
patient who received preservation of the posterior chords
had a sudden death event shortly after the 1-year echocar-
diographic study, probably as a result of arrhythmia and
end-stage heart failure. The percentage changes of the echo-
cardiographic parameters after 1 year from baseline in these
4 patients are summarized in Figure 3.
Discussion
Although the merits of chordal preservation during MVR
have been examined in numerous clinical studies, the results
have not been uniform because of the retrospective nature of
the investigations, heterogeneous patient populations,
mixed valvular pathology, and the absence of controlled,
randomized trials. Furthermore, despite laboratory findings
supporting the contribution of all chordal structures to LV
systolic function in the normal canine heart,20-22 the impor-
tance of retaining the anterior subvalvular apparatus in
addition to the posterior leaflet in patients with chronic
mitral insufficiency remains controversial. Therefore this study
was undertaken to determine the immediate and delayed
effects of complete versus partial chordal-sparing MVR.
Consistent with reports of other investigators,2,4,8,15,18,23-27
the correction of the volume overload caused by chronic
mitral insufficiency decreased EDV postoperatively inde-
pendent of the operative technique, although there was a
greater reduction when all chords were retained. However,
only in the C-MVR cohort did EDV decline further after 1
year. Similarly, ESV decreased early after complete chord-
al-sparing MVR, which is concordant with previous obser-
vations1,2,4,7,8,28 and continued to decrease with time. In
contrast, ESV remained relatively unchanged in the P-MVR
group. This discordant change in ESV is explained by the
interdependence of the changes in ESS (consequently ESV),
EF, and EDV after MVR. According to the mathematic
model validated by Goldfine and colleagues,29 for any EDV,
a lower EF is associated with a larger ESV and, by virtue of
the Laplace relation, a higher ESS. Therefore the greater
reduction in EF in patients with partial chordal preservation
can result in an increase in ESS and ESV despite a decrease
in EDV. In contrast, because of a relatively higher postop-
erative EF and a greater decline in EDV, it was not unex-
TABLE 1. Selected patient characteristics according to
procedure type
Characteristics P-MVR (n  15) C-MVR (n  21) P value
Age 59 11 56 13 .48
Male sex 4 15 .02





Values are means  1 SD.
NYHA, New York Heart Association.
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pected to observe a decrease in both ESS and ESV in the
C-MVR cohort. These findings suggest that preserving all
chordal structures results in more favorable LV geometry
and, consequently, LV afterload. This, in turn, leads to
greater ventricular remodeling, as supported by the fact that
a larger reduction in LVM was seen after 1 year (26% vs
4%). In a prospective analysis of 14 patients undergoing
MVR, Popovic and associates6 also noted a decrease in
LVM index in patients who had complete chordal preser-
vation compared with those with excision of both leaflets.
In this analysis EF and LAFS were used as measures of
LV ejection performance. At discharge, EF and LAFS were
lower than preoperative values in both groups, but the
declines were less than one half as much in the C-MVR
cohort (13% vs 28% and 14% vs 38%, respectively). The
relative preservation of these parameters was likely the
result of the complete maintenance of the papillary-annular
continuity. This is supported by other studies2,8,30,31 dem-
onstrating a reduction in fractional shortening in the LV
regions subtended by the papillary muscles.
Nonetheless, it was still rather surprising to find the
initial small decrease in EF and LAFS because others have
reported no change in EF after chordal-sparing
MVR.1,2,4,7,25,27 However, EF is highly load dependent32
and a poor indicator of LV systolic function in patients with
chronic mitral insufficiency caused by the imposed abnor-
mal loading conditions.33 Because ESS decreased and the
ESS/ESV ratio remained relatively unchanged in the C-
MVR group, the decreases in EF and LAFS were not due to
augmented afterload or deterioration in LV function but
rather to the greater abrupt fall in preload associated with
correction of the volume overload situation. In contrast, the
reduction in ESS/ESV in the P-MVR cohort suggests that a
real decline in LV systolic performance was partly respon-
sible for the decrease in EF and LAFS. Okita and col-
leagues2 also noted higher ESS/ESV ratios in patients un-
dergoing complete chordal-sparing MVR compared with
those after conventional MVR. Whereas EF and LAFS
returned to baseline values in the C-MVR group after 1
year, these parameters remained depressed in the P-MVR
TABLE 2. Echocardiographic measurements according to procedure type






P-MVR (n  15) 145 57* 114 52 112 41 .0001
C-MVR (n  21) 176 36* 118 24† 107 28 .0001
P value (group) .05 .75 .63
ESV (mL) .0001
P-MVR 46 24 56 31 50 20 .09
C-MVR 60 13* 50 12† 40 11 .0001
P value (group) .03 .45 .06
ESS (kdyne/cm2) .0001
P-MVR 99 34 99 29 113 24 .07
C-MVR 120 19* 90 16† 104 16 .0001
P value (group) .02 .24 .21
LAFS (%) .0001
P-MVR 20 5* 12 4 12 3 .0001
C-MVR 17 3 14 2†‡ 17 2 .0001
P value (group) .07 .02 .0001
EF (%) .0001
P-MVR 70 12* 51 15 56 6 .0001
C-MVR 64 8 56 7†‡ 63 4 .0001
P value (group) .10 .19 .0007
LVM (g) .0001
P-MVR 206 76 210 80 192 63 .12
C-MVR 220 44 234 49 163 39§ .0001
P value (group) .42 .29 .10
ESS/ESV (kdyne/cm2-mL) .0002
P-MVR 2.63 1.33 2.24 1.27‡ 2.59 0.98 .02
C-MVR 2.07 0.43 1.84 0.32 2.78 0.72§ .0001
P value (group) .08 .17 .51
Values are means  1 SD.
P value (time  group), influence of time and procedure type; P value (time), changes with time in each group; P value (group), intergroup differences.
*P  .05 versus discharge and 1 year.
†P  .05 versus 1 year.
‡P  .05 versus before the operation.
§P  .05 versus before the operation and discharge.
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cohort. Although the ESS/ESV ratio trended toward the
preoperative value in those with posterior chordal preserva-
tion only, loading conditions became more unfavorable, as
evident by the rise in ESS. On the other hand, even though
ESS increased slightly by 1 year in the C-MVR group, a true
improvement in LV systolic function was likely, as demon-
strated by the 35% increase in the ESS/ESV ratio.
We are aware of only 4 other clinical investigations4,7,8,34
addressing the issue of C-MVR versus P-MVR in terms of
LV mechanics. Although the groups both at the National
Institutes of Health4 and the Medical University of South
Carolina7 demonstrated the superiority of chordal-sparing
MVR over conventional MVR, no significant differences
were noted between patients receiving either posterior or
bileaflet chordal preservation. However, the total number of
patients in each study was relatively small (14 and 8,
respectively) thereby reducing the likelihood of detecting a
statistical difference. Similarly, Straub and associates34 re-
Figure 1. Percentage changes ( SEM) in echocardiographic variables at discharge from preoperative level
according to procedure type (*P  .009; P < .001).
Figure 2. Percentage changes ( SEM) in echocardiographic variables after 1 year from preoperative level
according to procedure type (*P < .001).
Yun et al Surgery for Acquired Cardiovascular Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 123, Number 4 711
A
CD
ported improved LV volumes and ejection performance
with chordal preservation compared with resection at 3
months postoperatively. Although no differences were de-
tected between partial versus complete chordal-sparing
techniques, bileaflet retention resulted in relatively pre-
served regional wall motion. Furthermore, the analysis was
complicated by the fact that 31% of patients in whom partial
or complete chordal preservation was possible received
additional aortic valve replacement. Lastly, in a study at the
Saga Medical School in Japan, Natsuaki and colleagues8
retrospectively compared the effects of complete versus
partial chordal-sparing MVR. Consistent with our findings,
retaining all subvalvular structures resulted in declines in
EDV and ESV, without a significant change in EF. Preserv-
ing only the posterior chords, on the other hand, was asso-
ciated with a lower postoperative EF and a smaller decrease
in ESV.
Several limitations of this study should be addressed.
First, because data were not available for 7 patients as a
result of loss to follow-up, perioperative death, and poor-
quality echocardiograms, the number of patients was
smaller than anticipated. Consequently, the statistical power
to detect differences among the cohorts was lower. Despite
this shortcoming, significant improvements were noted with
complete chordal preservation compared with partial reten-
tion.
Second, we do not have a good explanation for the
differences in the preoperative parameters between the 2
groups other than small sample size. However, the selection
bias would have been against the C-MVR group because
these patients had larger preoperative EDV, ESV, and ESS
values, as well as lower values of EF, LAFS, and ESS/ESV
ratio. The fact that this cohort had superior LV mechanics,
both immediately after MVR and at 1 year, provides further
support for the importance of preserving all chordal struc-
tures.
Third, reading of the echocardiograms may not be totally
blinded because it is possible to distinguish between com-
plete and partial chordal preservation with detailed exami-
nation of the studies. However, all measurements were
independently verified by a second echocardiographer who
had no knowledge of the purpose of the study.
Finally, 4 patients in this study had preoperative LV
end-systolic dimensions greater than 50 mm. Their echo-
cardiographic data were excluded from analysis to avoid a
potential bias to the analysis. Indeed, as shown in Figure 3,
LV volumes and systolic performance deteriorated at 1 year
in this group of patients. Only one patient had improved
hemodynamics, and this individual had all chordae tendi-
neae retained. A repeat analysis of the data was performed
to ensure the validity of our findings, which included these
4 patients. Although the statistical P values changed
slightly, the overall results of the study were relatively
unaltered.
In conclusion, complete retention of the mitral subval-
vular apparatus during MVR confers a significant early
advantage by reducing LV chamber size and systolic after-
load compared with that seen after partial chordal preser-
vation. Furthermore, LV ejection performance continues to
improve at 1 year as a result of improved remodeling.
Therefore when MVR is necessary, we recommend that
attempts should be made to preserve all chordal structures to
Figure 3. Percentage changes ( SEM) in echocardiographic variables after 1 year from preoperative level in
patients with a preoperative end-systolic dimension of greater than 50 mm.
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optimize early postoperative and late LV systolic function.
Additionally, a preoperative systolic diameter of 50 mm or
greater may portend a poor prognosis.
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Discussion
Dr Edward D. Verrier (Seattle, Wash). Thank you for the
opportunity to discuss this interesting clinical study performed at
Los Angeles Kaiser Permanente and analyzed at a number of
prestigious institutions. Preliminary analysis of these data with
similar conclusions was published in Circulation in 1999, although
the 1-year follow-up data were not included. Dr Yun has done an
excellent job presenting the data.
Over the past 20 years, we have certainly increased our under-
standing of the complex anatomic and physiologic functions of the
mitral valve apparatus. Dr Craig Miller, one of the authors of this
presentation and past president of the Western Thoracic Surgical
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Association, has contributed much to that basic understanding
through elegant animal models.
One clear concept from that research that is applicable to MVR
and based on extensive clinical experience with mitral valve repair
techniques is the importance of preserving annular, chordal, and
muscle continuity to preserve LV function. Surgeons, however,
have been somewhat reluctant to adopt complete anterior and
posterior chordal preservation in contrast to simply preserving the
posterior leaflets because of the very real concerns of increased
technical complexity, longer operating time, partial interference
with mechanical valve leaflet motion, and the potential of creating
LV outflow tract obstruction, particularly with very myxomatous
valves, when leaving the anterior leaflet.
No previous prospective, randomized trial has compared com-
plete versus partial or posterior preservation of the chordal appa-
ratus during MVR. This is particularly important on the basis of
the recent insights of the importance of the mitral apparatus on the
hot topic of ventricular remodeling.
I have a few concerns and questions for the author. My first
concern is that this is a single-institution, essentially single-sur-
geon study. Could there be a selection bias? The reason I ask is
based on the following reasoning and observations. First, when
you look at the echocardiographic results presented in the manu-
script in Table 2, the complete versus the partial groups from
baseline are really different. The preoperative EDV, ESV, ESS,
LAFS, LVM, and ratio of stress to volume all have P values of
between .2 and .8. With such a small cohort size in each group, one
greater or one fewer patient in either group could make a rather
profound difference in the statistics. The overall ventricular size
was larger in both diastole and systole in the complete chordal-
sparing group. Therefore might one not speculate a better func-
tional echocardiographic result with any type of chordal sparing?
The second factor that may affect the conclusions on the basis
of selection is that of the 47 patients initially entered into this
study. Eleven, or 21%, were excluded for a variety of reasons. This
seems like a very high number. How was the randomization
process done? Why were the initial ventricular volumes so differ-
ent? And do you think that it would be worthwhile to perform a
multi-institutional trial, or are you confident that there was no
selection bias?
Dr Yun. To answer your question, the randomization was
computer generated. We really have no good explanation for the
differences in the preoperative parameters between the 2 groups
other than perhaps small sample size. We agree that a multi-
institutional trial is worthwhile to confirm our findings. However,
we are confident that there was no selection bias because all
patients were randomized, and all data were analyzed and inde-
pendently verified at the end of the study. Any selection bias would
have been against the complete chordal-sparing group given the
larger ventricular volume and poor ejection performance preoper-
atively. The fact that this cohort performed better, both early and
late, provides further support to the importance of retaining the
whole mitral subvalvular apparatus.
Dr Verrier. My second question relates to the overall philos-
ophy of repair versus replacement. Most surgeons report an ap-
proximate 85% chance of repairing a regurgitant mitral valve,
particularly if myxomatous. For one institution to accumulate 47
patients over a 2-year period, that would roughly equate to over
312 patients operated on for mitral regurgitation and probably
more because all patients with mitral stenosis or concomitant
coronary artery disease were excluded. Why were so many MVRs
done, or do you now believe that MVR with complete chordal
preservation is superior to mitral valve repair?
Dr Yun. No, we do not believe that. We continue to advocate
mitral repair as the first option because of the overwhelming data
supporting mitral reconstruction in terms of LV systolic perform-
ance, including our previously published preliminary report. Al-
though MVR with complete chordal preservation may have the
same hemodynamic advantages, other beneficial effects of repair
in terms of avoiding prosthetic valve–related complications have
been demonstrated. I do not have the exact numbers, but over a
2-year span at our institution, approximately 5000 pump cases are
performed, of which about 250, or 5%, involved MVR for mitral
regurgitation. However, I must admit that our repair rate is likely
to be lower because of the fact that we are less tolerant of residual
mitral regurgitation compared with other, larger institutions.
Dr Verrier. My final question is related to the analysis of the
data. In the manuscript you stated that the echocardiograms were
read blindly. I have asked my senior echocardiographers at the
University of Washington whether they could recognize preserved
anterior or posterior chords after MVR. Although shadowing can
be a factor in transthoracic echoes, in most instances they thought
they could see the subchordal apparatus. Because this is primarily
an echocardiographic study, this concept seems important. How
could the echocardiographer be blinded at the time of the study if
they can see the chords, and could such knowledge then affect the
subsequent measurements, interpretation, or both? Might this also
be important because the authors carefully evaluated and previ-
ously published results with an n of 19 with the same conclusions
as in this study? Were the echocardiograms truly blinded?
Overall, I believe this prospective design and the clear conclu-
sions have important implications for the practicing cardiothoracic
surgeon. Thank you for the opportunity to discuss.
Dr Yun. Dr Zile, our echocardiographer, assures me that, given
the echogenicity of the mitral prosthesis, it is not a simple task to
distinguish between complete versus partial chordal preservation
without a detailed survey of the echocardiogram. Furthermore, all
measurements were independently verified by a second echocar-
diographer who had no knowledge of the purpose of the study.
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